Brevan Howard Capital Management’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-410
Closed -$13K 1017
2023
Q3
$13K Buy
+410
New +$13K ﹤0.01% 325